Schlagwort: ‘Government Supervision’
Improving the supply system of shortage medicines
Recently, the General Office of the State Council issued the “Guiding Opinions on Maintaining the Price and Supply of Shortage Medicines.” The “Guiding Opinion” stipulated that a national multi-source information collection platform for shortage medicines and a monitoring system for this platform should be established to realise information sharing of APIs (Active Pharmaceutical Ingredient) and pharmaceutical preparations in terms of their registration, production, procurement, and price. As for the drugs in the shortages list, pharmaceutical enterprises are allowed to quote their price on the provincial-level centralised drug procurement platform or on the internet so that medical institutions can purchase them on demand.
国办：强化药品价格常态化监管 完善短缺药品供应体系
来源：医药网 2019.10.14
近日，国务院办公厅印发《关于进一步做好短缺药品保供稳价工作的意见》（以下简称《意见》）。《意见》指出，应建立国家短缺药品多源信息采集平台和协同监测机制，实现原料药和制剂在注册、生产、采购、价格等方面的信息联通共享；对于短缺药品清单中的品种，允许企业在省级药品集中采购平台上自主报价、直接挂网，医疗机构自主采购。
“Prescription Sharing” supported
On September 29th, 21 commission and administrations, including the National Development and Reform Commission, the National Healthcare Security Administration, the National Health Commission, the National Medical Product Administration, jointly issued the “Guideline of Promoting a High-quality Development of the Health Industry (2019-2022).” The “Guideline” stipulated that channels for the interconnection and real-time sharing of information on drug consumption and on prescriptions of online diagnosis and treatment should be established nationwide. In the meantime, third-party platforms are suggested to deliver online prescribed drugs to encourage Medical e-commerces to offer “ordering online and delivered offline” services.
21部门发文力挺处方外流
来源：医药网 2019.09.30
9月29日，国家发改委、国家医保局、国家卫健委、国家药监局等21部委联合发布《促进健康产业高质量发展行动纲要（2019-2022年）》（下称“行动纲要”）。《行动纲要》要求，各地应建立互联网诊疗处方信息与药品零售消费信息互联互通、实时共享的渠道；支持在线开具处方药品的第三方配送；加速医药电商发展向患者提供“网订（药）店取，网订(药)店送”等服务。
Nationwide implementation of National Organised Centralised Procurement and Use of Drugs
On September 24th, 2019, more than 20 provinces and districts all over the country have launched a joint procurement of drugs. Thereby the pilot work on National Organised Centralised Procurement and Use of Drugs is extended from 11 big cities to nationwide. The price of all medicines was lower than the price of selected drugs in “4+7.”
医保局：国家组织药品集中采购和使用试点扩至全国
来源：医药网 2019.09.25
9月24日，全国二十多个省、区启动药品联合招标采购，国家组织药品集中采购和使用试点由11个城市扩大至全国。在此次扩围采购中，药品价格都降低到不高于此前11个试点城市中选价格的水平。
The National Medical Insurance Bureau issued new regulations
On August 30th, the National Medical Insurance Bureau issued the “Guidelines of Improving the price management of the ‘Internet+’ Medical Services and the Policies of Medical Insurance Payment.” The “Guidelines” proposed that the price management of the “Internet+” medical services should be included in the policy system of general medical services to realise a unified regulation. The eligible “Internet+” medial services will be regulated under proper medical insurance payment policies in accordance with the principle of online and offline consistency, and its management of medical insurance agreement(Every citizen contracts with a specific hospital) and the settlement process should be improved.
国家医保局公布新规，影响所有医药人
来源：医药网 2019.09.02
8月30日，国家医保局发布《关于完善“互联网+”医疗服务价格和医保支付政策的指导意见》（以下简称《指导意见》）。《指导意见》提出，应将“互联网+”医疗服务价格纳入先行医疗服务价格的政策体系统一管理；符合条件的“互联网+”医疗服务，按照线上线下公平的原则配套医保支付政策，并根据服务特点完善协议管理、结算流程。
The revised “Pharmaceutical Administration Law” allows the online selling of prescription drugs
On August 26th, the revised “Pharmaceutical Administration Law” was approved by the Twelfth Session of the Thirteenth Standing Committee of the National People’s Congress and will come into effect on December 1st, 2019. The “Pharmaceutical Administration Law” proposed that the Marketing Authorisation Holders and pharmaceutical companies can sell drugs online on the premise of complying with relevant provisions. Vaccines, narcotic drugs, and other drugs under special control are not included.
新《药品管理法》对网售处方药开了绿灯
来源：医药网 2019.08.27
8月26日， 新修订版《药品管理法》经十三届全国人大常委会第十二次会议表决通过，并将自2019年12月1日起施行。法案提出，药品上市许可持有人、药品经营企业可在遵守法案关于药品经营的有关规定的前提下通过网络销售药品。疫苗、麻醉药品等国家实行特殊管理的药品不得在网络上销售。
Catalog of medical insurance (2019 Version) is released
On August 21st, the State Council issued the “National Medicine Catalogue of Basic Medical Insurance, Work Injury Insurance, and Maternity Insurance (2019 version),” which will be implemented from January 1st, 2020. The “Medicine Catalogue” Indicates that each provincial Medical Insurance Bureau should bring all the drugs of the “Medicine Catalogue” into the “Centralised Procurement” and update the drug database according to the use of drugs in local medical institutions and retail pharmacies. Meanwhile, a national unified drug database should be established to realise the unified management of codes of western medicine, Chinese traditional medicine, and hospital-made medicines.
2019版国家医保目录正式发布
来源：医药网 2019.08.21
8月21日，国务院发布《国家基本医疗保险、工伤保险和生育保险药品目录》（以下简称《目录》），并自2020年1月1日起开始实施。《目录》要求，各省级医疗保障部门应及时将《目录》内药品纳入当地药品集中采购范围，并根据辖区内医疗机构和零售药店药品使用情况，及时更新完善药品数据库。同时，应建立完善全国统一的药品数据库，实现西药、中成药、中药饮片、医院制剂的编码统一管理。
Heilongjiang: The detailed rules of drug price supervision is going to be implemented
On August 9th, the Medical Insurance Bureau of the Heilongjiang province issued the “Notification of Supervising Drug Price and Distribution Information.” The “Notification” stipulates that the supervision of drug price and distribution information should be carried from drug manufacturers, distribution enterprises, medical institutions, retail pharmacies, and public sentiment. The mechanisms for information collection, reporting, analysis, investigation, and processing should be improved at the provincial, city, and county levels.
药品价格监测地方细则来了！月月报送、五方联动……
来源：医药网 2019.08.12
8月9日，黑龙江省医保局发布了《关于做好药品价格和配送信息检测工作的通知》（以下简称《通知》）。《通知》指出，应从药品生产企业、配送企业、医疗机构、定点零售药店和社会舆情五个方面开展药品价格和配送信息检测；健全并完善省、市、县三级联动的信息采集、报送、分析、调查、处理机制。
The Xi’an Municipal Government launches the submission of increased purchase of selected drugs(“4+7”)
On August 6th, the Xi’an Municipal Government issued the “Notification on Launching the Submission of Increased Purchase of Selected Drugs in Xi’an from the ‘Office of the Leading Group for the Implementation of Centralized Drug Procurement and Pilot Work’”. It is decided to increase the purchase of selected drugs in Xi’an because its procurement exceeds expectations. Besides, the deferred payment of the increased procurement should be paid in time.
“4+7″采购量完成超预期，启动中选药品增加采购量报送
来源：医药网 2019.08.07
8月6日，西安市发布《落实国家组织药品集中采购和试点工作领导小组办公室关于启动西安地区中选药品增加采购量报送工作的通知》。因西安地区”4+7″准备采购量完成情况已经超过预期，经研究，决定启动西安地区中选药品增加采购量报送工作。同时，对于增加的采购量，应确保及时回款。
Zhejiang takes the lead in implementing DRGs payment
On July 18th, the Zhejiang Medical Insurance Bureau issued the “Opinions on Promoting the Reform of Basic Medical Insurance Payment Methods for Medical Communities in Zhejiang Province,” and plans to implement multiple and composite medical insurance payment methods under total budget management. For inpatient medical services, the payment is mainly based on the DRGs (Diagnosis-Related Groups) system. For long-term and chronic disease inpatient medical services, the “daily payment for each sickbed” will be gradually promoted. For outpatient medical services, the “per-head payment” will be implemented, which also combines the “Contracted Family Doctor Services”.
市场洗牌来了！浙江率先全面推行DRGs点数法付费
来源：医药网 2019.07.19
7月18日，浙江省医保局发布《关于推进全省县域医共体基本医疗保险支付方式改革的意见》，计划全面推行总额预算管理下的多元复合式医保支付方式；对住院医疗服务，主要按DRGs（疾病诊断相关分组）点数法付费；对长期、慢性病住院医疗服务，逐步推行按床日付费；对门诊医疗服务探索结合家庭医生签约服务，实行按人头付费。
“List of National Intensive Monitoring Drug” is released
On July 1st, the Medical Administration Bureau of the National Health Commission issued the “Notification on printing the first List of National Intensive Monitoring Drug (Chemicals and Biological Products),” 20 drugs were selected in the “List.” The “Notification” stipulates that all provinces should form a list of provincial intensive monitoring drug on the basis of the national “List” and publish it for use by various medical institutions. All medical institutions should establish a regulatory system for monitoring drugs and strengthen the management of clinical applications of them. At the same time, the prescription management of drugs outside the “List” should also be strengthened.
重磅！国家重点监控药品目录公布
来源：医药网 2019.07.02
核心提示：7月1日，国家卫健委医政医管局发布了《关于印发第一批国家重点监控合理用药药品目录（化药及生物制品）的通知》，共20个药品入选。 《通知》要求， 各省应在《目录》基础上形成省级重点监控合理用药药品目录并公布，以供各类医疗机构参考；各医疗机构要建立重点监控合理用药药品管理制度，加强目录内药品临床应用的全程管理；同时，还应加强目录外药品的处方管理。